Search Our Scientific Publications & Authors

Publications
find publications by category +
Translate page:

Is volume and leak monitoring feasible during nasopharyngeal continuous positive airway pressure in neonates?

Authors:
Hendrik S Fischer Charles C Roehr Hans Proquitté Hannes Hammer Roland R Wauer Gerd Schmalisch

Intensive Care Med 2009 Nov;35(11):1934-41

Clinic of Neonatology CCM, Charité University Medicine Berlin, Charité platz 1, 10117 Berlin, Germany.

Objective: To investigate tidal volume (VT) and leak measurements during continuous positive airway pressure (CPAP) in neonates using a commercial ventilatory device equipped with a flow sensor at the Y-piece.

Design: Randomized cross-over trial.

Setting: Neonatal intensive care unit level III.

Patients: Thirty-two infants, median (range) birth weight 1,435 (710-2,730) g, gestational age 30 (24-38) weeks.

Interventions: During nasopharyngeal CPAP, leak and VT were measured with and without occlusion of the contralateral nostril using the Leoni ventilator (Heinen & Löwenstein, Germany) and a recently developed algorithm to correct measured VT in the presence of leaks. The measuring range of the Leoni is limited to leaks <90%.

Main Results: Analyzable measurements with leaks <90% could be obtained in 12.5% of the patients with open nostril, and in 65.6% with occluded nostril. Calculated leak flow after nostril occlusion was 23 (3-77) ml min(-1) with closed mouth. Leak flow increased significantly if mouth was opened (548 (0-1,394) ml min(-1), p<0.001), but was probably even higher where leaks exceeded 90%. Mean expiratory volume +/- SD was 5.8 +/- 1.3 ml kg(-1) (corrected VT 5.9 +/-1.2 ml kg(-1)) for leaks <20%, and 3.7 +/-1.4 ml kg(-1) (corrected VT 5.8 +/- 2.2 ml kg(-1)) for leaks between 20 and 69%.

Conclusions: Leak and corrected VT could be determined in the presence of leaks of up to 69%, but leaks during CPAP often exceeded the measuring range. Reliable volume and leak monitoring was not possible with the tested equipment during nasopharyngeal CPAP. Advanced equipment is necessary to further investigate the effects of leaks on neonatal CPAP therapy.

Download full-text PDF

 Source
http://dx.doi.org/10.1007/s00134-009-1651-9DOI Listing
November 2009

Publication Analysis

Top Keywords

airway pressure
8
positive airway
8
continuous positive
8
volume leak
8
heinen löwenstein
4
intensive care
4
ventilator heinen
4
iiipatients thirty-two
4
level iiipatients
4
unit level
4
neonatal intensive
4
care unit
4
trialsetting neonatal
4
leak measured
4
developed algorithm
4
flow sensor
4
y-piecedesign randomized
4
germany developed
4
löwenstein germany
4
cross-over trialsetting
4

Similar Publications

Apnea-hypopnea index supplied by CPAP devices: time for standardization?

Authors:
Alphanie Midelet Jean-Christian Borel Renaud Tamisier Ronan Le Hy Marie-Caroline Schaeffer Najeh Daabek Jean-Louis Pépin Sébastien Bailly

Sleep Med 2021 Feb 16;81:120-122. Epub 2021 Feb 16.

Laboratoire Hypoxie et Physiopathologie cardiovasculaire et respiratoire (HP2), INSERM U1042, Grenoble Alpes University, Grenoble, France.

Background/objective: For obstructive sleep apnea (OSA) patients on continuous positive airway pressure (CPAP) treatment, the apnea-hypopnea index (AHI) is a key measure of treatment efficacy. However, the residual AHI is CPAP brand specific. Here, we studied changes in residual AHI in patients who used two different brands over their treatment history. Read More

View Article and Full-Text PDF
February 2021
Similar Publications

Pitolisant versus placebo for Excessive Daytime Sleepiness in Narcolepsy and Obstructive Sleep Apnea: A Meta-Analysis from Randomized Controlled Trials.

Authors:
Jiahe Wang Xiang Li Siyuan Yang Tianyi Wang Zhongmou Xu Jianguo Xu Heng Gao Gang Chen

Pharmacol Res 2021 Mar 2:105522. Epub 2021 Mar 2.

Department of Clinical Medicine, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu Province, China. Electronic address:

Excessive daytime sleepiness is considered as the prominent symptom in narcolepsy and Obstructive Sleep Apnea (OSA). Pitolisant is a novel selective histamine H3 receptor antagonist approved for improving excessive daytime sleepiness. The meta-analysis is conducted to assess the efficacy and safety of pitolisant versus placebo for excessive daytime sleepiness in narcolepsy and OSA. Read More

View Article and Full-Text PDF
March 2021
Similar Publications

Recommended approaches to minimize aerosol dispersion of SARS-CoV2 during noninvasive ventilatory support can deteriorate ventilator performances: a benchmark comparative study.

Authors:
Maxime Patout Emeline Fresnel Manuel Lujan Claudio Rabec Annalisa Carlucci Léa Razakamanantsoa Adrien Kerfourn Hilario Nunes Yacine Tandjaoui-Lambiotte Antoine Cuvelier Jean-François Muir Cristina Lalmoda Bruno Langevin Javier Sayas Jesus Gonzalez-Bermejo Jean-Paul Janssens

Chest 2021 Mar 2. Epub 2021 Mar 2.

Division of Pulmonary Diseases, Geneva University Hospitals (HUG), Switzerland; Faculty of Medicine, University of Geneva, Switzerland.

Background: SARS-CoV-2 aerosolization during noninvasive positive pressure ventilation may endanger healthcare professionals. Various circuit setups have been described in order to reduce virus aerosolization. However, these setups may alter ventilator performances. Read More

View Article and Full-Text PDF
March 2021
Similar Publications

High-flow therapy: physiological effects and clinical applications.

Authors:
Rebecca F D'Cruz Nicholas Hart Georgios Kaltsakas

Breathe (Sheff) 2020 Dec;16(4):200224

Lane Fox Clinical Respiratory Physiology Research Centre, Guy's and St Thomas' NHS Foundation Trust, London, UK.

Humidified high-flow therapy (HFT) is a noninvasive respiratory therapy, typically delivered through a nasal cannula interface, which delivers a stable fraction of inspired oxygen ( ) at flow rates of up to 60 L·min. It is well-tolerated, simple to set up and ideally applied at 37°C to permit optimal humidification of inspired gas. Flow rate and should be selected based on patients' inspiratory effort and severity of hypoxaemia. Read More

View Article and Full-Text PDF
December 2020
Similar Publications

The differences in plasma/serum ghrelin levels between obstructive sleep apnea-hypopnea patients and controls: A protocol for systematic review and meta-analysis.

Authors:
Meng-Ling Sun Xun Niu Xi-Yue Xiao Xiong Chen

Medicine (Baltimore) 2021 Feb;100(8):e24368

Department of Otolaryngology-Head and Neck Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology.

Background: The association between obstructive sleep apnea-hypopnea syndrome (OSAHS) and plasma/serum ghrelin levels remains controversial. We performed a meta-analysis to evaluate the difference in plasma/serum ghrelin levels between OSAHS patients and controls.

Methods: Database of PubMed, SCI, and Elsevier were searched entirely. Read More

View Article and Full-Text PDF
February 2021
Similar Publications